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Abstract
Background:  Growing evidence indicates that ambient air pollution is associated with
exacerbation of chronic diseases like chronic pulmonary disease. A prospective panel study was
conducted to investigate short-term changes of blood markers of inflammation and coagulation in
response to daily changes in air pollution in Erfurt, Germany. 12 clinical visits were scheduled and
blood parameters were measured in 38 male patients with chronic pulmonary disease during
winter 2001/2002. Additive mixed models with random patient intercept were applied, adjusting
for trend, weekday, and meteorological parameters. Hourly data on ultrafine particles (UFP, 0.01-
0.1 μm), accumulation mode particles (ACP, 0.1-1.0 μm), PM10 (particulate matter <10 μm in
diameter), elemental (EC) and organic carbon (OC), gaseous pollutants (nitrogen monoxide [NO],
nitrogen dioxide [NO2], carbon monoxide [CO], and sulphur dioxide [SO2]) were collected at a
central monitoring site and meteorological data were received from an official network. For each
person and visit the individual 24-hour average of pollutants immediately preceding the blood
withdrawal (lag 0) up to day 5 (lag1-4) and 5-day running means were calculated.
Results: Increased levels of fibrinogen were observed for an increase in one interquartile range of
UFP, PM10, EC, OC, CO, and NO revealing the strongest effect for lag 3. E-selectin increased in
association with ACP and PM10 with a delay of one day. The ACP effect was also seen with the 5-
day-mean. The pattern found for D-dimer was inconsistent. Prothrombin fragment 1+2 decreased
with lag 4 consistently for all particulate pollutants. Von Willebrand factor antigen (vWF) showed
a consistent decrease in association with almost all air pollutants with all lags except for lag 0. No
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associations were found for C-reactive protein, soluble intercellular adhesion molecule 1, serum
amyloid A and factor VII.
Conclusion: These results suggest that elevated concentrations of air pollution are associated
with changes in some blood markers of inflammation and coagulation in patients with chronic
pulmonary disease. The clinical implications of these findings need further investigation.
Background
Growing evidence indicates that air pollution is associated
with disease exacerbation and increased risk of cardiovascu-
lar death in cardiovascular patients [1] but also in patients
with chronic obstructive pulmonary disease (COPD) [2-4].
Hypothesised pathways between particulate air pollution
and cardiovascular disease include a particle induced lung
inflammation that affects the endothelium, thrombotic
potential and fibrinolytic balance in ways that favour plaque
rupture and thrombosis and a particle translocation in to the
blood that directly affects the endothelium [5]. Associations
between ambient air pollution and markers of inflammation
and coagulation have been shown in patients with cardio-
vascular disease [6]. In addition, increased circulating levels
of such mediators of inflammation and coagulation have
been found in patients with COPD [7,8]. This study was
designed specifically to investigate whether ambient air pol-
lution leads to an enhanced systemic inflammatory response
and changes in blood coagulability in patients with chronic
pulmonary disease. Repeated measurements of blood mark-
ers were compared with concurrent levels of gaseous and
particulate ambient air pollutants on a daily basis. Our
hypothesis was that inflammation and coagulation markers
would increase in association with higher levels of air pollu-
tion. The following parameters were measured: fibrinogen,
C-reactive protein (CRP), serum amyloid-A (SAA), E-selec-
tin, soluble intercellular adhesion molecule-1 (sICAM-1),
von Willebrand factor antigen (vWF), prothrombin frag-
ment 1+2, D-dimer, and factor VII (FVII).
Methods
Study design
A prospective panel study was performed between Octo-
ber 15, 2001 and May 6, 2002 in Erfurt, Germany. 38
male patients with chronic pulmonary disease were
recruited by practitioners or through newspaper advertise-
ment and invited for twelve clinical visits. In the repeated
measurement design each patient serves as his own con-
trol and therefore baseline characteristics of each patient
and other unknown confounders are automatically
adjusted for. At each visit a short interview was conducted
and blood samples were taken. At the first visit a baseline
questionnaire was administered regarding health status,
pulmonary and cardiac symptoms, medication use and
smoking history.
Written informed consent was obtained from all partici-
pants and the protocol was approved by the Ethics Com-
mittee Bavaria, Germany.
All methods used in the study were conducted according
to Standard Operating Procedures (SOP).
Ambient air pollution measurements and exposure 
assessment
Ambient air pollutants were recorded hourly at a fixed
monitoring station in the vicinity of the city centre of
Erfurt representing urban background levels. The particle
number size distribution was measured on a continuous
basis using two instruments covering different size ranges.
Both instruments, data analyses and quality control were
described in detail by Pitz et al. [9]. Briefly, number con-
centration for ultrafine particles (UFP, 0.01-0.1 μm) and
accumulation mode particles (ACP, 0.1-1.0 μm) were cal-
culated from each spectrum. For the online measurement
of the mass concentration of PM10 (particulate matter
with an aerodynamic diameter smaller than 10 μm) we
applied a Tapered Element Oscillating Microbalance
(TEOM Model1400a, Thermo Fisher Scientific Inc., USA).
Continuous mass concentration measurements of ele-
mental (EC) and organic carbon (OC) were determined
with an Ambient Carbon Particulate Monitor (ACPM,
Model 5400, Thermo Fisher Scientific Inc., USA). Concur-
rent data on meteorological variables like temperature,
relative humidity, and barometric pressure as well as gas-
eous pollutants like nitrogen monoxide (NO), nitrogen
dioxide (NO2), carbon monoxide (CO), and sulphur
dioxide (SO2) were obtained from the Thuringia state
monitoring network station in Erfurt. Missing values for
UFP, PM10, SO2, NO2, NO, temperature, and relative
humidity were imputed by a linear regression model
based on data from parallel measurements. The R-squares
for the UFP regression model was 0.93 and for PM10 0.79.
For each subject and visit, individual 24-hour averages of
pollutants immediately preceding the clinical visit (0-23
hours [lag 0], 24-47 hours [lag 1], 48-71 hours [lag 2], 72-
95 hours [lag 3], 96-119 hours [lag 4]) as well as a 5 day
average prior to the examination were calculated if more
than 2/3 of the hourly measurements were available for
this time period.Particle and Fibre Toxicology 2009, 6:25 http://www.particleandfibretoxicology.com/content/6/1/25
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Clinical measurements
For each patient 12 clinical visits were scheduled biweekly
on the same weekday (Monday to Friday) and same time
(8:00 am to 5:00 pm).
At each visit EDTA and citrate plasma samples were taken
(Becton Dickinson, NJ, USA). Samples were centrifuged
and aliquots were immediately stored at -20°C until anal-
ysis. CRP (high-sensitivity assay), SAA, and fibrinogen
were analyzed by immunonephelometry (Dade Behring,
Marburg, Germany). S-ICAM-1, E-selectin (R&D Systems,
Wiesbaden, Germany), and prothrombin fragment 1+2
(Dade Behring, Marburg, Germany) were measured by
means of a commercial ELISA. D-dimer and vWf were ana-
lyzed using an immuno turbidimetric method and FVII by
clotting time measurement (Stago, France).
Study population
Exclusion criteria were pacemaker, insulin dependent dia-
betes mellitus, recent myocardial infarction (MI), bypass-
surgery or balloon dilatation less than three months ago,
unstable angina, asbestosis and silicosis. Additionally,
patients on anticoagulation therapy and those who were
hospitalized more than three times in the six months
prior to the start of the study because of their lung disease
were not eligible. Moreover, patients who took antibiotics
more than four times in the six months prior to the start
of the study or the winter (October to March) prior to the
study could not participate.
The data of 38 of 42 males could be included in the anal-
yses. One patient was excluded because of cancer diag-
nosed after the study had started. Data of three other
people could not be used as they had only one single
measurement.
Out of 456 possible visits a total of 452 visits were accom-
plished, indicating completeness of over 99%. 21 blood
samples (5% of total visits) were excluded from analyses
because the patients reported fever during the last week.
Thirty additional blood samples (7% of total visits) were
withdrawn because clinical examiners diagnosed an acute
respiratory infection. Furthermore, in 46 visits (10% of
total visits) patients reported an acute respiratory infec-
tion during the two weeks prior to the examination with-
out current signs of infection. For these cases, a risk
variable (airway infection) was built and tested for con-
founding effects. Finally, not all patients were able to give
the intended amount of blood at each visit. Therefore
between 347 (77% of total visits) and 380 (84% of total
visits) blood samples remained for analysis depending on
the marker.
Statistical analyses
The longitudinal data were analyzed using SAS Version
9.1 (SAS Institute Inc.) using additive mixed models with
random patient intercepts. To model the correlation
between repeated measurements in each patient we
assumed a compound symmetry structure for the covari-
ance matrix, because the half-lives of the markers were
shorter than the intervals between visits.
Prothrombin fragment 1+2, CRP, and D-dimer were log
transformed because their residuals remained skewed
after multivariate modelling.
In a first step, a confounder selection without blood mark-
ers was conducted for every blood marker separately.
Model fit was based on the lowest value of the Akaike
Information Criterion (AIC). Long-term time trend and
air temperature, relative humidity, and barometric pres-
sure, each with lag 0 to lag 3, were considered as potential
confounders. In addition, five risk variables (airway infec-
tion, medical attendance, hospital admission, and corti-
costeroid or antibiotic intake during the two weeks prior
to the visit) were created and included into the model if
this improved the model fit. Also, an indicator variable for
weekday of the visit was added to the final confounder
model. Penalised splines (P-splines) were used to allow
for non-linear confounder adjustment.
Exposure variables were added one by one to the final
model as linear terms. Effect estimates are presented as
percent change of the arithmetic mean or geometric mean
(after log transformation) together with 95% confidence
intervals (CI) based on an increase in air pollution con-
centration from the 1st to the 3rd quartile (interquartile
range, IQR).
We performed a sensitivity analysis for all blood markers
with selected air pollutants excluding the seven current
smokers. Also, subgroup analyses for asthmatics and non-
asthmatics were conducted.
Results
Patient characteristics
Patient characteristics are shown in table 1. The study
population consisted of 38 men, aged 34 to 78 years.
Seven patients were current smokers and most of the
remaining participants were ex-smokers. The majority of
ex-smokers had stopped smoking more than ten years
before the start of the study. Two participants had stopped
three years and four years before the start of the study,
respectively, and two participants had stopped one year
before the start of the study. Only current smokers
reported smoking in the past 24 hours before the visits
while none of the non- or ex-smokers had smoked before
any of the visits.
Blood parameters
Levels of blood parameters are summarized in table 2.
Spearman correlations were found between the acuteParticle and Fibre Toxicology 2009, 6:25 http://www.particleandfibretoxicology.com/content/6/1/25
Page 4 of 13
(page number not for citation purposes)
phase response parameters (CRP and fibrinogen, r = 0.64;
CRP and SAA, r = 0.43; SAA and fibrinogen, r = 0.39) and
a moderate correlation was found between the adhesion
molecules E-selectin and sICAM-1 (r = 0.37). Markers of
the acute phase response were not correlated with adhe-
sion molecules (r = -0.13 to 0.29). Correlation was also
poor between the coagulation markers (r = -0.01 to 0.35).
Air pollutants
The descriptive statistics of daily average concentrations of
particulate, gaseous, and meteorological parameters are
presented in table 3. For the UFP measurements, 1257
missing values from the differential mobility particle sizer
(DMPS) were replaced by a combination of condensation
particle counter (CPC) and scanning mobility particle
sizer (SMPS) measurements. 26 missing PM10 data were
replaced by measurements from three other sites. Regard-
ing temperature and relative humidity, only three meas-
urements were missing and obtained from a different
measurement site. 156 NO2 measurements and 280 NO
measurements were substituted by data from other meas-
urement sites. As the exposure variables are missing inde-
pendent of the health outcomes they are assumed to be
missing completely at random (MCAR) which will not
bias the associations. Figure 1 illustrates UFP, PM10, and
temperature during the course of the study period. Spear-
man correlation coefficients were calculated for different
air pollution measurements. A high correlation was found
between ACP and PM10 (r = 0.9) as well as between OC
and EC (r = 0.93). UFP were moderately correlated to ACP
(r = 0.75). Correlations between particles and gaseous
pollutants were highest between ACP and CO (r = 0.72)
and NO2 (0.73), respectively.
Table 1: Characteristics of the study population, 38 men with a history of chronic pulmonary disease in Erfurt, Germany, winter 2001/
2002
Variable Mean ± DS†
Age [years] 53.8 ± 12.3
BMI* [kg/m2] 25.5 ± 3.7
N (%)
History of COPD
I (mild) FEV1/FVC < 70% and
FEV1/FEV1 predicted > 80%
2 (5)
II (moderate) FEV1/FVC < 70% and
50% ≤ FEV1/FEV1 predicted < 80%
7 (18)
III (severe) FEV1/FVC < 70% and
30% ≤ FEV1/FEV1 predicted < 50%
5 (13)
Chronic bronchitis† 29 (76)
Emphysema† 5 (13)
Bronchial asthma† 20 (53)
Coronary heart disease† 11 (29)
Angina pectoris† 15 (40)
Myocardial infarction† 8 (21)
Bypass surgery/balloon dilatation† 4 (11)
Hypertension† 14 (37)
Chronic heart failure† 2 (5)
Cardiac arrest† 1 (3)
Diabetes mellitus Type 2† 2 (5)
Allergic rhinitis† 11 (29)
Sleep apnea† 4 (11)
Chronic kidney disease† 2 (5)
Smoking history Ex smoker 23 (61)
Current smoker 7 (18)
Long-term medication use Patients with long-term medication 35 (92)
β2-agonists 22 (58)
Theophylline 17 (45)
Glucocorticosteroids 20 (53)
Antibiotics 5 (13)
Statins 6 (16)
COPD, Chronic obstructive pulmonary disease; ‡ SD, standard deviation; * BMI, Body mass index; †"ever physician diagnosed" determined by an 
interview with trained nurses; # FEV1, forced expiratory volume in 1 second; § FVC, forced vital capacityParticle and Fibre Toxicology 2009, 6:25 http://www.particleandfibretoxicology.com/content/6/1/25
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Regression results
Results for the linear regression of different blood markers
are summarized in table 4 and table 5.
Inflammatory markers
A consistent increase in fibrinogen was observed for lag 3
with all particulate pollutants except for ACP (table 4 and
figure 2) and also with CO and NO (data not shown). For
EC, CO, and NO this increase was also seen for lag 4 (data
for CO and NO not shown). Additionally, the 5-day-
mean concentrations of UFP demonstrated a positive sig-
nificant association.
For E-selectin, a significant increase was found with ACP
and PM10 for lag 1 (table 4). The ACP effect was also seen
for lags 0 and 2 and for the 5-day-mean.
Table 2: Biomarkers for 38 male Patients with history of chronic pulmonary disease in Erfurt, Germany, between October 2001 and 
May 2002
Variable No. Mean SD* Min. Med. 90% Max.
Fibrinogen
[g/l]
380 3.1 0.7 0.9 2.9 4.1 6.3
SAA
[mg/l]†
380 7.7 44.0 0.8 2.9 6.8 718.0
CRP
[mg/l]‡
380 3.8 8.4 0.2 1.6 7.5 127.0
E-selectin
[ng/ml]
380 50.3 20.9 4.0 47.3 77.7 116.2
sICAM-1
[ng/ml]§
380 302.8 104.3 120.7 274.4 419.0 855.9
Faktor VII
[% activity]
349 131.2 35.3 53.0 125.0 180.0 315.0
vWF
[% activity]#
349 126.4 43.4 25.0 126.0 186.0 213.0
D-dimer
[μg/ml]
349 0.5 0.6 0.02 0.3 0.9 3.8
Prothrombin fragment 1+2
[nmol/l]
347 2.2 1.0 0.6 2.1 3.5 6.0
* SD, standard deviation; † SAA, serum amyloid A; ‡ CRP, C-reactive protein; § sICAM-1, soluble inter-cellular adhesion molecule 1; # vWF, von 
Willebrand factor antigen
Table 3: Descriptive statistics of daily average concentrations of ambient particulate and gaseous air pollutants and meteorological 
variables in Erfurt, Germany, between October 2001 and May 2002
Variable No. Mean (± SD§) Min. Median Max. IQR# IQR5#
Number concentration [n/cm3]
UFP* 207 6604 (± 3147) 1547 5972 18845 3827 2918
ACP* 146 1094 (± 773) 211 866 3886 907.3 914.2
Mass concentration [μg/m3]
PM10 * 208 17.73 (± 10.29) 4.38 15.03 57.27 11.43 9.91
OC* 208 1.04 (± 0.46) 0.43 1.04 2.87 0.52 0.37
EC* 208 2.60 (± 1.96) 0.40 1.97 10.63 1.98 1.76
SO2 * 206 3.54 (± 2.61) 3.00 3.00 37.22 0.17 0.41
NO2 * 208 25.37 (± 9.90) 6.54 24.94 55.74 12.94 9.70
CO* 208 0.42 (± 0.16) 0.14 0.39 1.07 0.17 0.14
NO* 199 13.32 (± 10.48) 4.00 9.63 56.43 11.30 10.04
Meteorology
Air temperature
[°C]
208 4.23 (± 5.49) -12.83 4.79 15.71 8.13 6.85
Barometric pressure [hPa] 208 979.6 (± 10.5) 952.8 979.5 1002.3 14.6 11.8
Relative humidity
[%]
208 82.22(± 11.72) 48.75 84.40 100.00 15.44 12.27
* UFP, ultrafine particles, number concentration of particles with a size range of 0.01 to 0.1 μm in diameter; ACP, accumulation mode particles, 
particles with a size range of 0.1 to 1.0 μm; PM10, mass concentration of particles less than 10 μm in diameter; OC, organic carbon; EC, elemental 
carbon; SO2, sulfur dioxide; NO2, nitrogen dioxide; CO, carbon monoxide; NO, nitrogen monoxide; § SD, standard deviation; # IQR, interquartile 
range; IQR5, Interquartile range for 5 day averageParticle and Fibre Toxicology 2009, 6:25 http://www.particleandfibretoxicology.com/content/6/1/25
Page 6 of 13
(page number not for citation purposes)
CRP, sICAM-1, and SAA showed no significant association
with air pollutants (data not shown).
Coagulation markers
An inconsistent pattern was determined for D-dimer with
decreases for lag 0 (ACP and PM10) and lag 1 (UFP, PM10)
and increases for lag 3 (OC, EC only borderline). This pat-
tern was restricted to particulate pollutants (table 5).
Prothrombin fragment 1+2 decreased with lag 4 consist-
ently with all particulate pollutants except for UFP (table
5 and figure 2) and with NO (data not shown).
A consistent decrease in vWF was ascertained for all partic-
ulate pollutants for lag 2 and for the 5-day-mean (table 5
and figure 2). Except for PM10, this decrease was also seen
for lag 3 and lag 4. This pattern was also determined for
the gaseous pollutants NO2 and CO (data not shown),
however not that clear. A significant decrease of vWF was
also found for lag 1 with EC and OC.
No significant associations between FVII and air pollut-
ants were observed (data not shown).
Sensitivity analyses
Excluding the seven smokers from the analyses hardly
changed the results for most of the blood markers. Slightly
stronger associations were seen for fibrinogen and pro-
thrombin fragment 1+2 with PM10, EC and OC. Most
other results remained stable, however with slightly wider
confidence intervals, probably due to reduced number of
observations (Figure 3).
Subgroup analyses showed that there were hardly any dif-
ferences between asthmatics and non-asthmatics. Associ-
ations seemed slightly stronger for fibrinogen with UFP at
lags 2 and 3 and D-Dimer for ACP with lag 1. For E-selec-
tin few selected lags showed a slightly stronger association
for non-asthmatics (data not shown).
Discussion
Summary
We examined the association between ambient air pollu-
tion and a range of blood markers of inflammation and
coagulation in a panel of patients with chronic pulmo-
nary disease. We hypothesised that blood markers would
increase with increased levels of air pollution, confirming
the hypothesis that particles cause lung inflammation,
which might eventually induce a systemic inflammation.
We found a positive association between particulate air
pollution and fibrinogen for lag 3 and with E-selectin
especially for lag 1. Furthermore, vWf showed a consistent
decrease in association with almost all measured pollut-
ants. A negative association was also observed for lag 4 for
prothrombin fragment 1+2. No clear pattern was found
for D-dimer. No association between ambient air particles
and most markers of inflammation like CRP, SAA, sICAM-
1 or FVII were seen. Asthmatics do not seem to differ sig-
nificantly from non-asthmatics.
Inflammatory markers
Fibrinogen, an acute phase reactant and coagulation fac-
tor, is synthesised by hepatocytes and released in large
amounts into the circulation in response to interleukin-6
(IL-6) stimulation [10]. Increased concentrations of
fibrinogen are considered as indicators for an imbalance
in the hemostatic system and as risk factors for arterial
occlusive disorders such as MI or stroke [11]. During peri-
ods of COPD exacerbation, higher plasma levels of fibrin-
ogen were found and hypothesised to be associated with
cardiovascular morbidity and mortality [12]. Danesh et al.
recently published a meta-analysis of 31 prospective stud-
ies which clearly showed a strong and independent asso-
ciation between elevated plasma levels of fibrinogen and
various cardiovascular endpoints and total mortality [13].
This relationship suggests one explanation for the proven
link between cardiovascular risk and obstructive lung dis-
ease [14].
We found small but consistently increased mean levels of
fibrinogen in association with air pollution revealing the
strongest effect for lag 3. Higher levels of fibrinogen in
relation to PM10 were also measured in a sample of the
U.S. population [15]. Additionally, similar results were
found by Pekkanen et al. who reported higher fibrinogen
levels in association with air pollution [16]. One year
prior to this study a similarly designed study was con-
ducted in patients suffering from coronary heart disease
(CHD) [6]. The authors reported increases of CRP, SAA,
and sICAM-1 in association with air pollution. These
effects were restricted to higher values of these markers
Time series of number concentrations of particles sized 0.01  to 0.1 μm (ultra fine particles, UFP) and mass concentrations  of particles less than 10 μm in diameter (PM10) with air tem- perature in Erfurt, Germany between October 2001 and May  2002 Figure 1
Time series of number concentrations of particles 
sized 0.01 to 0.1 μm (ultra fine particles, UFP) and 
mass concentrations of particles less than 10 μm in 
diameter (PM10) with air temperature in Erfurt, Ger-
many between October 2001 and May 2002.Particle and Fibre Toxicology 2009, 6:25 http://www.particleandfibretoxicology.com/content/6/1/25
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above the 90th percentile using logistic regression models
while linear regression analyses failed to reveal significant
results. No association was found between fibrinogen and
air pollution in these data. In our study, a logistic regres-
sion with a cutoff above the 90th percentile was not possi-
ble because of poor intra-individual variability. The
reduced variability may be due to the chronic inflamma-
tion associated with chronic pulmonary disease and ele-
vated levels may indicate the severity of the disease.
Furthermore, particulate and gaseous ambient air pollu-
tion markers tended to decrease from winter 2000/2001
to winter 2001/2002 in Erfurt while meteorological mark-
ers were comparable. This could be caused for example by
a changed wind direction. It might also be possible that
this is the result of reduced-emission road traffic or less
factory fumes. However, the exposure to air pollution in
our study population was lower and adverse effects might
be smaller. This assumption is in agreement with Silkoff
et al. [17] who observed detrimental associations of air
pollution and worsened lung function in patients with
COPD only for the second of two investigated winters
with higher pollution levels.
Table 4: Effects of particulate pollutants on fibrinogen, E-selectin, and vWF presented as % change from the arithmetic mean in the 
blood marker (linear regression) per increase in IQR† air pollutant; 38 men with chronic pulmonary disease in Erfurt, Germany, 
between October 2001 and May 2002
Polutant Fibrinogen E-Selectin vWF††
%change AM†† 95%CI %change AM†† 95%CI %change AM†† 95%CI
UFP
Lag0# 0.5 -1.8 ; 2.9 -1.2 -3.9 ; 1.4 0.1 -2.7 ; 2.9
Lag1# 2.5 * 0.2 ; 4.9 0.2 -2.7 ; 3.1 -0.4 -3.3 ; 2.5
Lag2# -1.6 -4.3 ; 1.0 -2.0 -5.1 ; 1.0 -4.1 ** -7.3 ; -1.0
Lag3# 3.3 ** 1.0 ; 5.6 -1.1 -4.3 ; 2.0 -4.3 ** -6.9 ; -1.6
Lag4# 1.5 -0.5 ; 3.5 1.6 -1.1 ; 4.2 -4.0 ** -6.4 ; -1.6
5-day-mean# 3.1 * 0.2 ; 6.0 -0.9 -4.5 ; 2.7 -6.1 *** -9.7 ; -2.6
ACP
Lag0# 0.2 -3.7 ; 4.1 3.1 * 0.2 ; 6.1 2.6 -2.6 ; 7.7
Lag1# 0.5 -2.7 ; 3.7 4.0 ** 1.1 ; 6.9 -2.3 -6.4 ; 1.7
Lag2# -1.0 -3.9 ; 1.8 2.9 ** 0.4 ; 5.3 -4.9 ** -8.1 ; -1.6
Lag3# 1.3 -1.1 ; 3.7 1.3 -1.0 ; 3.6 -4.2 ** -7.2 ; -1.2
Lag4# 0.8 -1.7 ; 3.3 2.1 † 0.0 ; 4.2 -6.3 *** -9.7 ; -2.8
5-day-mean# 0.5 -3.6 ; 4.6 5.4 ** 1.7 ; 9.1 -6.8 * -12.2 ; -1.5
PM10
Lag0# 0.5 -1.7 ; 2.7 -1.1 -3.8 ; 1.6 2.1 -0.8 ; 5.0
Lag1# 0.1 -1.8 ; 2.0 2.6 * 0.2 ; 5.1 -1.6 -3.9 ; 0.7
Lag2# -0.5 -2.3 ; 1.3 1.1 -1.1 ; 3.4 -2.2 * -4.3 ; -0.1
Lag3# 2.4 ** 0.6 ; 4.1 -0.1 -2.5 ; 2.3 -2.4 * -4.7 ; -0.2
Lag4# 1.8 * 0.1 ; 3.5 0.3 -2.0 ; 2.6 -1.9 -4.2 ; 0.5
5-day-mean# 1.9 -0.5 ; 4.3 1.4 -1.9 ; 4.7 -3.3 * -6.6 ; -0.1
OC
Lag0# 0.1 -2.6 ; 2.7 -1.0 -4.1 ; 2.1 -1.1 -4.7 ; 2.4
Lag1# 0.1 -1.9 ; 2.1 2.7 * 0.2 ; 5.1 -3.3 ** -5.7 ; -0.9
Lag2# 0.1 -1.7 ; 1.9 0.6 -1.6 ; 2.9 -4.6 *** -6.7 ; -2.4
Lag3# 2.1 * 0.5 ; 3.6 0.1 -2.1 ; 2.2 -4.7 *** -6.9 ; -2.6
Lag4# 1.5 † -0.1 ; 3.1 0.6 -1.5 ; 2.7 -4.5 *** -7.0 ; -2.0
5-day-mean# 1.4 -0.5 ; 3.2 0.9 -1.5 ; 3.4 -6.4 *** -9.1 ; -3.6
EC
Lag0# 0.5 -1.9 ; 2.9 -2.1 -4.9 ; 0.7 -0.5 -3.6 ; 2.7
Lag1# 0.2 -1.7 ; 2.1 2.5 * 0.2 ; 4.7 -2.7 * -4.9 ; -0.4
Lag2# -0.5 -2.2 ; 1.3 0.8 -1.3 ; 2.9 -4.0 *** -6.1 ; -1.9
Lag3# 2.5 ** 0.9 ; 4.0 -0.2 -2.3 ; 1.9 -3.6 *** -5.5 ; -1.7
Lag4# 1.8 * 0.3 ; 3.2 0.7 -1.2 ; 2.6 -3.3 *** -5.4 ; -1.2
5-day-mean# 2.0 † -0.1 ; 4.1 0.9 -1.9 ; 3.7 -6.4 *** -9.4 ; -3.4
† IQR, interquartile range; ††AM: arithmetic mean; %-change: effect estimate obtained from regression divided by arithmetic mean of fibrinogen
vWF, von Willebrand factor antigen § UFP, ultrafine particles number concentration of particles with a size range of 0.01 to 0.1 μm in diameter; 
ACP, accumulation mode particles, particles with a size range of 0.1 to 1.0 μm; PM10, mass concentration of particles less than 10 μm in diameter; 
OC, organic carbon; EC, elemental carbon
# lag 0 (lag 1/lag 2/lag 3/lag 4/5-day-mean) = average pollutant concentration 0-23 (24-47/48-71/72-95/96-119/0-119) hours prior to blood 
withdrawal
* p < 0.05; ** p < 0.01; *** p < 0.001; † p ≤ 0.1Particle and Fibre Toxicology 2009, 6:25 http://www.particleandfibretoxicology.com/content/6/1/25
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In the UK, higher levels of CRP, the classical acute phase
protein, were documented in elderly subjects in associa-
tion to PM10 with a 3-day lag [18]. Moreover, the authors
reported no significant effect on the acute phase reactant
IL-6 levels but they noticed a reduction of fibrinogen in
contrast to our results. Pope et al. also found positive asso-
ciations between CRP and PM2.5 in elderly subjects in
Utah [19]. Interestingly, this association disappeared after
excluding the most influential subject determined by
residual analysis. Furthermore, the MONICA-Augsburg
study reported evidence of increased CRP for concentra-
tions above the 90th percentile in relation to air pollution
in healthy men [20].
Besides, in patients with COPD some investigators failed
to show a relationship between systemic and airway
inflammation, suggesting different regulation of inflam-
mation in the pulmonary and systemic compartment
[21]. This might be one reason why we were not able to
discover changes in plasma CRP, SAA, and sICAM-1. It is
Table 5: Effects of air pollution on D-dimer and prothrombin fragment 1+2 presented as % change from the geometric mean in the 
blood marker (linear regression) per increase in IQR† air pollutant; 38 men with chronic pulmonary disease in Erfurt, Germany, 
between October 2001 and May 2002
Pollutant D-Dimer Prothrombin fragment 1+2
%change GM†† 95%CI %change GM†† 95%CI
UFP
Lag0# 0.2 -8.0 ; 9.1 0.7 -3.5 ; 5.1
Lag1# -8.8 † -17.3 ; 0.6 4.1 † -0.4 ; 8.8
Lag2# -0.3 -8.8 ; 9.0 0.9 -3.5 ; 5.5
Lag3# 2.6 -5.6 ; 11.5 0.6 -3.3 ; 4.7
Lag4# 0.9 -6.4 ; 8.8 -2.6 -6.2 ; 1.2
5-day-mean# -1.1 -10.6 ; 9.5 1.4 -4.4 ; 7.6
ACP
Lag0# -13.3 * -24.0 ; -1.2 -0.9 -7.5 ; 6.2
Lag1# -5.8 -16.8 ; 6.5 3.1 -2.5 ; 9.0
Lag2# 2.5 -7.0 ; 12.9 3.0 -1.5 ; 7.8
Lag3# 6.4 -2.6 ; 16.4 -1.2 -5.3 ; 3.0
Lag4# 6.2 -4.0 ; 17.5 -6.3 ** -10.5 ; -1.9
5-day-mean# 0.4 -14.0 ; 17.3 -1.1 -8.5 ; 7.0
PM10
Lag0# -10.3 ** -17.3 ; -2.7 0.7 -3.8 ; 5.5
Lag1# -9.3 * -16.0 ; -2.1 0.6 -2.9 ; 4.2
Lag2# -1.7 -8.0 ; 5.1 0.6 -2.6 ; 3.8
Lag3# 4.3 -2.5 ; 11.6 -2.5 -5.9 ; 0.9
Lag4# 4.6 -2.4 ; 12.0 -5.1 ** -8.5 ; -1.6
5-day-mean# -3.6 -12.4 ; 6.1 -3.5 -8.9 ; 2.1
OC
Lag0# -6.0 -14.2 ; 3.0 -0.9 -6.3 ; 4.9
Lag1# -2.4 -9.5 ; 5.3 0.9 -2.8 ; 4.7
Lag2# 4.6 -1.9 ; 11.6 0.6 -2.9 ; 4.2
Lag3# 7.2 * 1.1 ; 13.7 -2.1 -5.7 ; 1.6
Lag4# 5.5 † -1.0 ; 12.5 -4.5 * -8.3 ; -0.6
5-day-mean# 3.9 -3.0 ; 11.4 -2.2 -6.9 ; 2.8
EC
Lag0# -4.1 -11.9 ; 4.3 2.6 -2.5 ; 7.8
Lag1# -3.5 -10.0 ; 3.5 1.7 -1.8 ; 5.3
Lag2# 3.2 -2.6 ; 9.4 1.2 -2.0 ; 4.6
Lag3# 5.3 † -0.3 ; 11.1 -2.5 -5.6 ; 0.8
Lag4# 3.8 -2.0 ; 9.9 -4.2 * -7.3 ; -0.9
5-day-mean# 3.1 -4.3 ; 11.2 -1.6 -6.8 ; 3.9
† IQR, interquartile range; GM: geometric mean (antilog of arithmetic mean of log-transformed variable); %-change: antilog of effect estimate 
obtained from regression minus 1 *100
§ UFP, ultrafine particles number concentration of particles with a size range of 0.01 to 0.1 μm in diameter; ACP, accumulation mode particles, 
particles with a size range of 0.1 to 1.0 μm; PM10, mass concentration of particles less than 10 μm in diameter; OC, organic carbon; EC, elemental 
carbon
# lag 0 (lag 1/lag 2/lag 3/lag 4/5-day-mean) = average pollutant concentration 0-23 (24-47/48-71/72-95/96-119/0-119) hours prior to blood 
withdrawal
* p < 0.05; ** p < 0.01; † p ≤ 0.1Particle and Fibre Toxicology 2009, 6:25 http://www.particleandfibretoxicology.com/content/6/1/25
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Effects of particulate ambient air pollutants on fibrinogen, prothrombin fragment 1+2, and von Willebrand factor antigen  (vWF), lag 0 to lag 4 and 5-day-mean exposure Figure 2
Effects of particulate ambient air pollutants on fibrinogen, prothrombin fragment 1+2, and von Willebrand fac-
tor antigen (vWF), lag 0 to lag 4 and 5-day-mean exposure. 38 men with chronic pulmonary disease in Erfurt, Ger-
many, between October 2001 and May 2002. IQR, interquartile range; UFP, ultrafine particles number concentration of 
particles with a size range of 0.01 to 0.1 μm in diameter; ACP, accumulation mode particles, particles with a size range of 0.1 to 
1.0 μm; PM10, mass concentration of particles less than 10 μm in diameter; OC, organic carbon; EC, elemental carbon; lag 0 (1, 
2, 3, 4, 5-day-mean) = average pollutant concentration 0-23 (24-47; 48-71, 72-95, 96-119, 0-119) hours prior to blood with-
drawal.
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Comparison of associations between blood markers and PM10 for all observations (black circle) and observations without  smokers (black square) for fibrinogen, E-selectin and prothrombin fragment 1+2 lag 0 to lag 4 and 5-day-mean exposure Figure 3
Comparison of associations between blood markers and PM10 for all observations (black circle) and observa-
tions without smokers (black square) for fibrinogen, E-selectin and prothrombin fragment 1+2 lag 0 to lag 4 
and 5-day-mean exposure. 31 male non-smokers and 7 male smokers with chronic pulmonary disease in Erfurt, Germany, 
between October 2001 and May 2002. IQR, interquartile range; PM10, mass concentration of particles less than 10 μm in diam-
eter; lag 0 (1, 2, 3, 4, 5-day-mean) = average pollutant concentration 0-23 (24-47; 48-71, 72-95, 96-119, 0-119) hours prior to 
blood withdrawal.Particle and Fibre Toxicology 2009, 6:25 http://www.particleandfibretoxicology.com/content/6/1/25
Page 11 of 13
(page number not for citation purposes)
possible that analyses of sputum samples would have
shown effects of air pollutants in our patient sample. Of
interest, in this context, is the observation that in the case
of COPD exacerbation, systemic inflammatory response is
related to the magnitude of the lower rather than upper
airway inflammation [22]. This leads to the assumption
that particles with less diameter like UFP might be more
harmful than larger particles because of a higher pulmo-
nary deposition [23]. UFP have only been rarely assessed
in the studies referenced above [6].
Our results support the idea that almost all examined par-
ticulate parameters and also some gaseous air pollutants
are associated with increased fibrinogen levels in patients
with chronic pulmonary disease. High fibrinogen levels
are considered to be associated with a faster decline in
lung function [24]. Therefore, air pollution might lead to
a more rapid lung function decline in these susceptible
patients as shown in the SAPALDIA study [25].
In addition, we observed increased levels of E-selectin that
may reflect higher endothelial cell activation, as an
increased expression of adhesion molecules is known to
reflect activation of the vascular endothelium [26]. How-
ever, we did not find air pollution effects for the adhesion
molecule sICAM-1.
Coagulation markers
Patients with COPD are at higher risk of thrombotic
events and increased levels of blood markers of coagula-
tion have been found [7]. Prothrombin fragment 1+2 is
cleaved from prothrombin when activated to thrombin,
representing a marker of activation of the coagulation
pathway [27]. Elevated levels have been found in COPD
patients [7]. We observed decreases of prothrombin frag-
ment 1+2 associated with increases of air pollution. This
finding contrasts our hypothesis of enhanced coagulabil-
ity. For most of the coagulation factors, changing the level
between 50% and 150% has little effect on thrombin gen-
eration. But in the case of prothrombin, the rate of
thrombin generation, peak activity reached and total
amount of thrombin produced are proportional to the
prothrombin level [28]. Thus, our results may reflect a
delayed reduction of coagulation due to air pollutants.
We found similar results with vWF. On the one hand, vWF
is known as a factor of the coagulation process [29] and
on the other hand, vWF may serve as a marker of endothe-
lial perturbation [30]. VWF is synthesized and stored in
platelets, megacaryocytes, and endothelial cells [31].
Plasma concentrations of vWF are elevated in coronary
artery disease [32] and may predict future cardiovascular
mortality [33]. The results of vWF do not confirm our
hypothesis that air pollution leads to enhanced endothe-
lial cell activation and increased coagulability in patients
with chronic pulmonary disease. However, vWF is a non-
specific marker [30] and cautious interpretation of our
results is needed; especially as E-selectin showed quite a
different pattern. D-dimer is a breakdown product of
cross-linked fibrin, [34] and there is growing evidence that
there may be an association between elevated levels of D-
dimer and increased risk of future MI [35]. In our study,
D-dimer showed an inconsistent pattern in association
with air pollution parameters. It is possible that the
observed increase found with lag 3 for EC and OC corre-
sponds to the changes in fibrinogen. But previous studies
report only modest correlations between D-dimer and
fibrinogen [35], and we did not find high correlations
either. The decrease of D-dimer found for lag 0 and lag 1
did not reflect the pattern of the other investigated mark-
ers of coagulability.
Strengths and limitations
Our longitudinal study achieved over 99% of all sched-
uled visits indicating high compliance. The exposure to a
variety of particles and gaseous pollutants was ascertained
and numerous markers reflecting different pathways were
measured. The detected effects are small and most proba-
bly only relevant to those subjects whose levels are at ends
of the distribution.
We excluded blood samples from patients with obvious
clinical signs of airway infection and adjusted for risk var-
iables like airway infection, medical attendance, and hos-
pital admission during the two weeks prior to the visit.
This conservative approach may reflect another reason for
the failure of verifying immunological effects for all mark-
ers in this relatively small study group.
Moreover, we adjusted for meteorological variables and
long term time trend to minimize the possibility that the
detected associations resulted from meteorological influ-
ences or seasonal differences. The co-morbidities of our
subjects might also modify the effects of our results, as
patients included in the study had different concomitant
diseases and used several medications. Therefore, adjust-
ments for an intake of corticosteroids and antibiotics were
made.
The detected associations are only small and might be
considered sub-clinical. However, even small changes
may indicate a disrupted haemostasis. Moreover, small
but consistent associations can give ideas for possible
underlying pathways and are therefore interesting for
research, even if they might be considered irrelevant in a
clinical context. Finally, many acute little changes may
also lead to atherosclerotic progression and chronic
effects.
No assessments of indoor and individual personal expo-
sures were conducted. However, Cyrys et al. [36] have
shown that ambient air pollution can be used as surrogateParticle and Fibre Toxicology 2009, 6:25 http://www.particleandfibretoxicology.com/content/6/1/25
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measures for indoor exposure of for example PM2.5 and
black smoke if major indoor sources are absent. Addition-
ally, analyses in two European cities showed that ambient,
indoor and personal concentrations of PM2.5 were highly
correlated [37]. Ebelt et al. [38] also demonstrated that
the component of personal exposure due to outdoor par-
ticles and ambient concentrations were highly correlated,
especially for PM2.5 but also for PM10 and therefore data of
ambient monitoring sites can be used in time series anal-
yses.
Only about one third of our study population had a severe
COPD and therefore comparison to some of the cited
studies might be difficult. However, all of our patients
were diagnosed with chronic pulmonary disease. Due to
the selection criteria the results of this study are not repre-
sentative of the general population but limited to male
persons of similar age and disease status.
Conclusion
This study provides evidence that ambient air pollution is
associated with blood markers of inflammation and coag-
ulation in patients with chronic pulmonary disease. These
markers are known as risk factors for adverse cardiovascu-
lar events such as myocardial infarction and stroke and
confirm therefore a hypothesised pathway between air
pollution and cardiovascular disease in a panel of patients
with chronic pulmonary disease. To what extend the
observed changes may lead to disease exacerbation needs
further investigation.
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